SYNOPTICS, INC

Synoptics, Inc. specializes in the design, development, and manufacturing of high-precision analytical laboratory instruments, with demonstrated expertise in advanced diagnostic and research-grade systems. Their core capabilities center on the engineering of sophisticated instrumentation for scientific and clinical applications, including protocol-driven analytical platforms that support reproducible, high-throughput data acquisition. The company brings deep competency in embedded systems, sensor integration, microfluidics, and laboratory automation, ensuring instruments meet rigorous standards for accuracy, reliability, and regulatory alignment in sensitive environments. A recent award for the PROTOCOL3HD SYSTEM underscores their ability to deliver complex, mission-critical analytical platforms tailored to demanding laboratory workflows, likely incorporating real-time data processing, multi-channel detection, and compliance with clinical and research validation protocols. Synoptics, Inc. has established a focused relationship with the Department of Health and Human Services, providing specialized analytical instrumentation that supports public health research, disease surveillance, and laboratory diagnostics. Their work for HHS suggests alignment with initiatives requiring high-fidelity data generation for biomedical analysis, likely serving agencies such as CDC, NIH, or FDA through tailored instrument solutions that enable precision measurement and regulatory compliance. The company’s primary NAICS code, 334516, reflects its niche in analytical laboratory instrument manufacturing—a sector that bridges engineering, life sciences, and regulatory compliance. Synoptics positions itself as a technical supplier to government-funded research and public health laboratories, specializing in custom or semi-custom instrumentation rather than commoditized equipment. As a small business structured as a 2L entity based in Frederick, Maryland, Synoptics operates with agility and technical focus, serving federal clients through direct contract performance. While currently holding no formal government certifications, its location in a region rich with biomedical and defense research infrastructure enhances its access to specialized talent and collaborative opportunities within the federal science ecosystem.